In the present study, we explored the clinical significance of methionine cycle genes, including GNMT, MAT1A and MAT2A mRNA levels in breast carcinoma using RNA-seq data from the TCGA/GTEx datasets within GEPIA2, and further validated the findings in our own breast cancer cohort by immunohistochemistry. This evidence concerns the gene MAT2A and breast carcinoma.